BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF- signaling with potential for durable tumor growth inhibitionSrinivas Reddy Boreddy,Reshmi Nair, Prashant Kumar Pandey,Anshu Kuriakose,Arindam Banerjee, Chaitali Dey, A. R. Madhukara,Bhadravathi Marigowda Shivakumar, Hanumant Kulkarni,Milind Sagar, M. V. Prashantha Kumar,Shiv Ram Krishn,Jaya Bhatnagar,Moni Abhram Kuriakose,Ram Bhupal Reddy,Amritha Suresh,Praveen Reddy Moole,Usha Bughani,Seng-Lai Tan,Pradip Nair, Rachel SalazarCANCER RESEARCH(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要